Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP701423.RA9QLJdVo5aMaLFdWo1m_YuIXB8K044jCy32gB6KI2qdk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP701423.RA9QLJdVo5aMaLFdWo1m_YuIXB8K044jCy32gB6KI2qdk130_assertion type Assertion NP701423.RA9QLJdVo5aMaLFdWo1m_YuIXB8K044jCy32gB6KI2qdk130_head.
- NP701423.RA9QLJdVo5aMaLFdWo1m_YuIXB8K044jCy32gB6KI2qdk130_assertion description "[Together, our findings suggest that selectively targeting tumor-elicited myeloid cells or versican represents a potential therapeutic strategy for combating metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP701423.RA9QLJdVo5aMaLFdWo1m_YuIXB8K044jCy32gB6KI2qdk130_provenance.
- NP701423.RA9QLJdVo5aMaLFdWo1m_YuIXB8K044jCy32gB6KI2qdk130_assertion evidence source_evidence_literature NP701423.RA9QLJdVo5aMaLFdWo1m_YuIXB8K044jCy32gB6KI2qdk130_provenance.
- NP701423.RA9QLJdVo5aMaLFdWo1m_YuIXB8K044jCy32gB6KI2qdk130_assertion SIO_000772 22282653 NP701423.RA9QLJdVo5aMaLFdWo1m_YuIXB8K044jCy32gB6KI2qdk130_provenance.
- NP701423.RA9QLJdVo5aMaLFdWo1m_YuIXB8K044jCy32gB6KI2qdk130_assertion wasDerivedFrom befree-20140225 NP701423.RA9QLJdVo5aMaLFdWo1m_YuIXB8K044jCy32gB6KI2qdk130_provenance.
- NP701423.RA9QLJdVo5aMaLFdWo1m_YuIXB8K044jCy32gB6KI2qdk130_assertion wasGeneratedBy ECO_0000203 NP701423.RA9QLJdVo5aMaLFdWo1m_YuIXB8K044jCy32gB6KI2qdk130_provenance.